Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO) (VK584026)

Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO)
Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO)
Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO)
Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO)
Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoVK584026
Descripción
Miromavimab (VK584026) is a research-grade recombinant antibody targeting G/Glycoprotein. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesRabies virus (RABV)
AplicacionesELISA, Bioactivity: FACS, Functional assay, Research in vivo
Especie huéspedMouse
ClonalidadMonoclonal
IsotipoIgG1, kappa
Sistema de expresión Mammalian cells
Objetivo G/Glycoprotein
Nivel de endotoxinas < 10 EU/mg
Pureza >95% purity as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso P03524
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativosM777-16-3, 2247163-73-9
Fondo

Glycoprotein is a ~58 kDa protein. Attaches the virus to host cellular receptor, inducing endocytosis of the virion by using different host proteins including TFRC, GRM2 and ITGB1. In the endosome, the acidic pH induces conformational changes in the glycoprotein trimer, which trigger fusion between virus and cell membrane. There is convincing in vitro evidence that the muscular form of the nicotinic acetylcholine receptor (nAChR), the neuronal cell adhesion molecule (NCAM), and the p75 neurotrophin receptor (p75NTR) bind glycoprotein and thereby facilitate rabies virus entry into cells.

Nota For research use only. Not suitable for clinical or therapeutic use.
Imágenes
  • Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO)

    Bioactivity

    Detects G/Glycoprotein in indirect ELISAs.

  • Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO)

    SDS-PAGE

    SDS-PAGE for Anti-RABV Glycoprotein G Reference Antibody (Miromavimab, RUO)

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores